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ABSTRACT We have employed the recently described crystallohydrodynamic approach to compare the time-averaged domain
orientation of human chimeric IgG3wt (wild-type) and IgG4wt as well as two hinge mutants of IgG3 and an IgG4S331P (mutation
fromserine to proline at position 331,EUnumbering)mutant of IgG4. Theapproach involves combination of the knownshapeof the
Fab and Fc regions from crystallographywith hydrodynamic data for the Fab and Fc fragments and hydrodynamic and small angle
x-ray scattering data for the intact IgG structures. In this way, ad hoc assumptions over hydration can be avoided and model
degeneracy (uniqueness problems) can beminimized. The best ﬁtmodel for the solution structure of IgG3wt demonstrated that the
Fab regions are directed away from the plane of the Fc region andwith a long extended hinge region in between. The best ﬁt model
of the IgG3m15 mutant with a short hinge (and enhanced complement activation activity) showed a more open, but asymmetric
structure. The IgG3HM5 mutant devoid of a hinge region (and also devoid of complement-activation activity) could not be
distinguished at the low-resolution level from the structure of the enhanced complement-activating mutant IgG3m15. The lack of
inter-heavy-chain disulphide bond rather than a signiﬁcantly different domain orientation may be the reason for the lack of
complement-activating activity of the IgG3HM5mutant.With IgG4, there are signiﬁcant and interesting conformational differences
between the wild-type IgG4, which shows a symmetric structure, and the IgG4S331P mutant, which shows a highly asymmetric
structure. This structural differencemay explain the ability of the IgG4S331Pmutant to activate complement in stark contrast to the
wild-type IgG4 molecule which is devoid of this activity.
INTRODUCTION
One of the most important functions of IgG is to react with
the complement system initiated by the binding of two or
more IgGs to the surface of pathogens followed by an inter-
action with C1q (1) leading to complement activation and
subsequent elimination of pathogenic agents. An important
factor initiating this activation process is the spatial orien-
tation of the domains of the IgG molecule. This may be a
time-averaged orientation because of potential ﬂexibility in
the hinge region, the extent of this ﬂexibility depending on
the IgG subclass. Despite the high degree of amino-acid
sequence homology, the four human IgG subclasses differ
markedly in their ability to activate the classic complement
pathway. IgG1 and IgG3 can active-complement effectively,
IgG2 only activates complement when the target antigens are
in high concentration (1,2), and IgG4 is inactive (3,4). Se-
quence homology analysis has shown the greatest difference
among the human IgG subclasses resides in the hinge region
(5).
In general, the hinge element can be divided into three
structurally discrete regions: the upper, middle, and lower
hinges (6). The upper hinge (UH) was deﬁned by Beale and
Feinstein (7) and depicted by Burton (8) as the number of
amino acids between the end of the ﬁrst heavy-chain con-
stant region domain (CH1) and the ﬁrst cysteine forming an
inter-heavy-chain disulphide bridge. The middle hinge (MH)
stretching from the ﬁrst to the last inter-heavy-chain cysteine
is believed to be rigid due to the inter-heavy-chain disulphide
bridging and the formation of polyproline helices (9,10). The
lower hinge (LH) begins at the last hinge disulphide and
connects to the amino terminus of the CH2 domain. The LH
is postulated to be ﬂexible and have an extended conforma-
tion independence on the presence of the Fab arms but be
critically modulated by the MH (6).
It has long been considered that the hinge region serves as
a spacer and mediates the segmental ﬂexibility allowing the
two Fab arms to assume a variety of orientations in space
relative to the Fc (11–14). Using nanosecond ﬂuorescence
depolarization technique, Dangl and co-workers (12) have
observed correlations between segmental ﬂexibility and
complement ﬁxation activity with the relative length of the
upper hinge (UH) region. However, we have found that
segmental ﬂexibility and spacer properties of the genetic
hinge were of little importance to complement activation
(15,16). In a more recent study (17), the authors have sys-
tematically generated 26 hinge variants by site-directed
doi: 10.1529/biophysj.107.108993
Submitted March 16, 2007, and accepted for publication June 22, 2007.
Address reprint requests to S. E. Harding, E-mail: steve.harding@
nottingham.ac.uk.
Editor: Jill Trewhella.
 2007 by the Biophysical Society
0006-3495/07/12/3733/12 $2.00
Biophysical Journal Volume 93 December 2007 3733–3744 3733
mutagenesis to investigate the relationship between the
hinge characteristics and the human IgG1 effector functions.
The hinge length or amino-acid sequence, and thereby pre-
sumably the ﬂexibility (or rigidity) of the UH or middle
hinge (MH), resulted in changes in effector functions.
These mutation studies have provided evidence that the
hinge may module complement activation in an indirect
mode by inﬂuencing the conformation of the binding sites in
the molecule or possibly altering the overall conformation of
the antibody molecule in solution (17–19). Structural anal-
ysis of antibodies will therefore facilitate the design of novel
antibodies that possess optimal combinations of effector func-
tions and hence allow for more speciﬁc and deﬁned manipula-
tion of the protective activities of IgG molecules.
Unfortunately, the application of high-resolution struc-
tural techniques like x-ray crystallography to immunoglob-
ulins have proved difﬁcult, due to the inherent ﬂexibility of
an intact antibody rendering crystallization or interpretation
of electron density maps problematic (10,20). Crystal struc-
tures of the intact antibody molecules are currently only con-
ﬁned to the hingeless mutants Dob (21), Mcg (22), and
Kol (23), and the wild-type intact IgGs Mab231 (24,25),
Mab61.1.3 (26), and human IgG1 b12 molecule (27). Com-
parisons of the crystal structures of these intact antibodies
have indicated that the differences in the orientation of the
two Fab regions relative to the Fc region inﬂuence the ef-
fector function (20,28). This structure-function correlation
has also been reported in immune complex formation studies
using electron microscopy—studies indicating that the two
Fab arms can adjust their orientations to accommodate the
particular orientation of any cognate epitope array (29–32).
To gain an insight into the structure-function relationship
of antibodies in solution, we have previously proposed the
crystallohydrodynamics approach for describing the time-
averaged domain orientation of antibodies in solution. The
approach is to combine x-ray crystallography of the IgG Fab
and Fc fragments with data from the measured hydrody-
namic properties of the fragments and the intact IgG mole-
cule (33,34) to specify possible low-resolution domain
orientations without the ad hoc assumptions concerning
time-averaged hydration used by other approaches (35–38).
The methodology has been further reﬁned by combining
sedimentation, small angle x-ray scattering, and viscometry
techniques to reduce the degeneracy or model uniqueness
problem (39). The domains are represented as low-resolution
bead-shell ellipsoids linked together by a hinge region. A
range of 1001 possible domain orientations are generated by
the model-producing algorithm MONTESUB (40) and the
best model or models are selected on the basis of agreement
of modeled hydrodynamic parameters with experimental
hydrodynamic parameters. In this way, the low-resolution
domain orientation of human IgG3 has been described (39).
The structural approximations for individual Fab and Fc
regions as simple ellipsoids allow us to concentrate on the
spatial arrangements within the antibody molecule that may
modulate its effector function (33,34,39,41). The Fab re-
gions can be approximated as prolate ellipsoid shapes (with
two equal minor axes, of semi-axial length b, and one longer
major axis, of semi-axial length a, and shape deﬁned by the
axial ratio a/b). The Fc domain is approximated by an oblate
ellipsoid shape (with two equal major axes, of semi-axial
length a, and one shorter minor axis, of semi-axial length b,
and shape also deﬁned by the axial ratio a/b). To facilitate
calculation of the hydrodynamic properties of the intact anti-
body molecule, the surface of each ellipsoidal region is then
represented by an array of beads. The hinge region joining
the Fab and Fc regions is represented by linear arrays of fric-
tionless beads.
We now use this procedure to study the time-averaged
Fab-Fc orientation of a chimeric IgG3 and two of its hinge
mutants, one with 15 amino-acid hinge IgG3m15 (IgG3
normally has 62 amino acids in the hinge) and one altogether
without hinge, IgG3HM5. Changes in orientations caused by
the mutations may correlate with the different abilities
of these antibodies to activate the complement cascade.
IgG3m15 has a greater complement activation ability than
wild-type IgG3 (15,16,42), while IgG3HM5 is completely
devoid of complement activation activity (16). We also adopt
a similar approach to investigate how a single amino-acid
substitution from Ser to Pro at position 331 in human IgG4
alters the overall conformation of the molecule—a change
known to confer a dramatic improvement of complement-
activation activity (19,43). Solution conformations of these
IgG3 and IgG4 wild-type and mutant molecules are sought
and an attempt made to relate the best-ﬁt models with com-
plement activation. In doing so, we were not able to follow
the complete crystallohydrodynamics approach as there was
insufﬁcient material to obtain reliable viscosity data for the
range of proteins analyzed. However, the measurement of
sedimentation coefﬁcient, radius of gyration, and maximum
particle dimension, together with the known structure of the
antibody regions, provided sufﬁcient information to tackle
the model degeneracy problem.
MATERIALS AND METHODS
Antibodies
All the antibodies used in our study (Fig. 1) are chimeric (mouse/human)
molecules that share speciﬁcity for the hapten 5-iodo-4-hydroxy-3-nitro-
phenacetyl. The production and puriﬁcation of the IgG3 wild-type antibody
and two hinge mutants (IgG3m15 with 15 amino acids in the hinge and
IgG3HM5 without the genetic hinge) are as reported previously (15,16,42).
Production of the chimeric IgG4 antibody and the mutant IgG4S331P with
serine at position 331 (EU numbering) replaced by proline have been
described in Brekke et al. (43). A comparison of the amino-acid sequences in
the hinge region is given in Table 1.
Sedimentation velocity
Sedimentation velocity experiments were performed using a Beckman
Optima XLA analytical ultracentrifuge (Palo Alto, CA) running at 40,000
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rpm at 20C. The solute concentrations were recorded as ultraviolet ab-
sorbance at 280 nm. Sedimentation proﬁles were analyzed by the least-
squares g*(s) method as implemented in SEDFIT (44) and sedimentation
coefﬁcients were corrected to standard conditions (density and viscosity of
water at 20C) to give so20,w.
Small angle x-ray scattering (SAXS)
SAXS was performed in Station 2.1 at the Synchrotron Radiation Source
(SRS, Daresbury, UK), employing camera lengths of 1.0 m (to cover a
Q-range of 0.038, Q, 0.32 A˚1) and 4.3 m (for 0.008, Q, 0.18 A˚1).
The detector was calibrated with wet rat tail collagen and silver behenate.
Data were collected at different antibody concentrations (ranging from 0.4
mg/mL to 11.4 mg/mL). Using the standard Daresbury software package
XOTOKO (45), data were then normalized to the intensity of the incident
beam, radially averaged, and corrected for the detector response. The total
scattering intensity from each of the time frames was determined to check for
beam-induced aggregation in the sample. Those frames showing increasing
counts were excluded from further analysis as the increase was considered to
be due to radiation-induced aggregation.
After subtracting the buffer contribution, to correct for the interparticle
interaction effects in the low-angle region of the high concentration mea-
surement, the low-angle regions of the low concentration data were scaled
to merge with the high-angle regions of the high concentration data using
SigmaPlot (Systat Software, San Jose, CA). The distance distribution func-
tion p(r) and the maximum dimension (Dmax) were obtained by using
GNOM (46). The radii of gyration (Rg) were determined by using both the
Guinier approximation (47) and GNOM.
Hydrodynamic bead modeling
As described previously (39), the solution properties (including sedimen-
tation coefﬁcient, so20,w, and the radius of gyration Rg) of an antibody mol-
ecule were determined experimentally. Their corresponding universal shape
functions (Perrin P, and Mittelbach G functions) were then derived from the
experimentally determined quantities (Table 2).
Bead-shell modeling (i.e., the surface of the particle is represented by a
shell-like assemblage of many identical minibeads) was chosen as our
modeling strategy based on the recognition that shell models are hydrody-
namically more appropriate as hydrodynamic resistance mainly takes place
on the surface of the particle (48). However, it is worth reiterating that the
ﬁlling bead procedure (i.e., the particle is ﬁlled with scattering elements), as
opposed to the shell bead procedure for the calculation of hydrodynamic
properties, was included in the calculation of the radius of gyration and other
scattering related properties that are speciﬁcally dependent on the particle
volume.
Candidate bead-shell models (.100) of differing domain orientations
were constructed for each hinge arrangement using MONTESUB (40), and
chosen to cover a representative range of possible orientations. The
hydrodynamic properties of the candidate models were then calculated using
HYDROSUB (49) and SOLPRO (50,51). Matches were then sought be-
tween the set of calculated shape functions (Table 2) for the models with the
experimental set. The maximum distance parameter Dmax from x-ray scat-
tering data was used as an additional ﬁlter in the selection of the appropriate
model(s).
RESULTS
Hydrodynamic characterization of the IgGs
Experimental values for the sedimentation coefﬁcient, s020,w,
radius of gyration Rg, and maximum particle dimensionDmax
for each antibody are given in Table 2. The corresponding
universal shape functions are then calculated using Eqs. 1–4
as described in Lu et al. (39), taking into account the effects
of the apparent hydration: a value of (0.596 0.07)g/g for the
latter is used, based on the crystal structure and hydrody-
namic data for the antibody domains (33). The experimental
errors associated with each measurement have been consid-
ered and evaluated as described in Lu et al. (39).
Under the same experimental conditions (namely rotor
speed, buffer, and temperature), the wild-type IgG3 sedi-
ments were slowest (6.11 6 0.02 S) among all the intact
antibodies investigated, consistent with previous ﬁndings
(33,53–55) that the extended hinge in IgG3 exerts an increased
translational friction for the sedimentation of the molecule. The
truncations of the hinge region in IgG3m15 and IgG3HM5
result in a more compact solution structures of these molecules
as demonstrated by the increase in sedimentation coefﬁcients,
despite the lower molecular weight. By contrast, sedimentation
TABLE 1 Hinge-region amino acids
IgG type UH MH LH
IgG3 ELKTPLGDTTHT CPRCP(EPKSCDTPPPCPRCP)3 APELLGGP
IgG3m15 EPKS CDTPPPCPRCP APELLGGP
IgG3HM5 — — APELLGGP
IgG4 ESKYGPP CPSCP APELLGGP
IgG4S331P ESKYGPP CPSCP APELLGGP
FIGURE 1 Schematic drawings of the ﬁve different chi-
meric IgG molecules analyzed in this study. The IgG3HM5
molecule has one S-S bridge between the two light chains.
For the variants of IgG3 and IgG4, common gray shades
represent common sequences.
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velocity experiments demonstrate that the single amino-acid
substitution, from Ser to Pro at position 331 in IgG4S331P, de-
creases the sedimentation coefﬁcient—indicative of a change
to a less compact solution structure.
These qualitative ﬁndings appear to be reinforced by the data
from SAXS (Table 2). The radius of gyration Rg is a measure
of the size and elongation of the scattering particle (56–58) and
G is the corresponding size-independent universal parameter
(39). Dmax, which can be obtained by transformation of the
scattering proﬁle into the distance distribution function p(r) of
scattering vectors (59), represents the maximum dimension of
the scattering particle.
Interestingly, both the ultracentrifuge and scattering data
show that the hingeless mutant IgG3HM5 behaves more like
an IgG4 molecule in solution (see Table 2). In comparison
with the two hingeless mutants Dob and Mcg, IgG3HM5 has
a sedimentation coefﬁcient more akin to Mcg (6.796 0.10 S)
than Dob (6.30 6 0.05 S) (33,54).
To get a more quantitative picture in terms of the time-
averaged domain orientations, we have employed hydrody-
namic bead modeling.
Hydrodynamic bead modeling strategy for
the IgGs
As described earlier (33,34,39,60), the two Fabs in an anti-
body molecule can be approximated to prolate ellipsoids and
the Fc as an oblate ellipsoid. The dimensions of the hydrated
ellipsoids used for representing the Fab and Fc domains are
shown in Table 3.
The hinge region (when signiﬁcant) in an antibody model
is represented as a Y-shape with each arm of the Y connected
to the Fab and the body of the Y linked to the Fc (Fig. 2). The
upper part (i.e., the arm) of the Y-shape represents the
ﬂexible upper hinge (UH) and the body part the Y-shape
represents the rigid middle hinge (MH). Therefore, we can
incorporate the known hinge sequence information in con-
structing the hinge region for a certain antibody molecule.
For instance, the body of the Y-hinge in IgG3 was con-
structed four times longer than the arm of the Y, based on the
sequence information that the MH in IgG3 is four times
longer than the UH (see Table 1). Using a deﬁned U-U-M
index for the beads arrangement in the hinge, in which U is
the number of beads in each branch of the upper hinge andM
is the number of beads in the middle hinge (39), the generic
hinge of IgG3 can be typically assigned as 2-2-8, 3-3-12,
4-4-16, etc., providing that a uniform bead size (radius of 1.8
A˚ in our study) is used.
In our modeling strategy (39), hinge ﬂexibility was mod-
ulated by altering the length and orientation of the arm and
body in the hinge using the Monte Carlo procedure as im-
plemented in MONTESUB (40). The advantage of using the
Monte Carlo procedure lies in that it generates a represen-
tative set of conformations covering all the possible spatial
arrangements allowed for the two Fab ellipsoids relative to
the Fc. The routine HYDROSUB calculates the values for
the set of universal shape functions (P, G, and n) for each
conformation—matches are then sought for the values of P,
G, and n calculated from experimental data, namely so20,w,
Rg, and n, respectively, together with the time-averaged
hydration value of (0.59 6 0.07)g/g obtained by comparing
crystal structure with hydrodynamic data for the domains.
Allowance is made for experimental errors (see Table 2) in
selecting candidate models. The number of possible models
is further reduced by the employment of the Dmax parameter
from the scattering data.
We have already described the solution conformation of
the wild-type IgG3 antibody when we described the ex-
tended crystallohydrodynamic approach (39). Following a
similar procedure, candidate models for the other four anti-
bodies (IgG3m15, IgG3HM5, IgG4, and IgG4S331P) have
now been found.
Bead modeling of the wild-type IgG3 (39)
A model (with U-U-M index of 6-6-24) that best reproduces
the shape functions (P and G) and the Dmax parameter was
found for the wild-type IgG3 antibody (39). Details of this
model are given in Table 4 and Table 5(a), in which u and u
are the spherical-polar angles referring to the orientation of
TABLE 3 Dimensions of the ellipsoids for representing the Fab
and Fc domains
Longest semiaxis (A˚) Shortest semiaxis (A˚)
Fab 39.30 24.35
Fc 36.60 21.63
TABLE 2 Experimental hydrodynamic data for the IgG3 and its hinge mutants (IgG3m15 and IgG3HM5), IgG4 and IgG4S331P
Mw (Da) n (mL/g) s
o
20,w (S) P Rg (A˚) G Dmax (A˚)
IgG3wt 156943 0.725 6.11 6 0.02 1.44 6 0.04 71.6 6 2.0 2.72 6 0.08 195 6 10
IgG3m15 146771 0.726 6.77 6 0.04 1.24 6 0.04 54.2 6 2.0 1.63 6 0.05 165 6 8
IgG3HM5 143529 0.727 6.68 6 0.03 1.23 6 0.04 54.8 6 2.0 1.65 6 0.05 163 6 8
IgG4wt 146076 0.725 6.66 6 0.08 1.26 6 0.04 54.0 6 2.0 1.62 6 0.05 161 6 8
IgG4S331P 146096 0.726 6.46 6 0.12 1.30 6 0.04 55.4 6 2.0 1.71 6 0.05 163 6 8
The partial speciﬁc volume (n) and molecular weight (Mw) of each antibody molecule in Table 2 are calculated using the SEDNTERP algorithm (52) from the
amino-acid sequence and carbohydrate content. Errors associated with each measurement are shown in italics. Table headings: so20,w, sedimentation
coefﬁcient; P, Perrin function; Rg, radius of gyration; G, reduced radius of gyration function; and Dmax, maximum dimension of the scattering particle.
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the main axis of each ellipsoid. The projection on the Z axis
for each Fab is the projection of the arm in the Y-shape hinge
(i.e., UH) on the Z axis, while for Fc is the projection of the
body in the Y-shape hinge (i.e., MH). Hinge distance be-
tween Fab and Fc can be referred to as the sum of the UH and
MH lengths on the Z axis. A negative value for the projection
on the Z axis indicates that the Fab arm is bent toward the Fc,
which could be also demonstrated by an obtuse value for u
(i.e., u . 90) of the main axis of the Fab.
As shown in Tables 4 and 5(a) and Fig. 3 a, it appears that
the two Fabs adopt difference orientations relative to the Fc,
which results in a slightly asymmetrical structure along the
long axis of Fc. The hinge length (sum of UH and MH
length) is ;80 A˚. This is in agreement with results from
immunoelectron microscopy studies by our collaborators
(31) that the mean hinge distance is 806 23 A˚ and consistent
with the earlier estimates of 90;100 A˚ of Pumphrey (14),
Gregory et al. (54), and Philips et al. (55).
Bead modeling of IgG3m15
The IgG3m15 mutant possesses only 15 amino acids in the
hinge. Bead models were constructed to try to reproduce the
experimental parameters as described for the wild-type IgG3.
Of the 1200 candidate models explored, one unique model
was found (with U-U-M index of 2-2-5), which was con-
sistent with the experimental P, G, and Dmax (Tables 4 and
5(b)).
FIGURE 2 Scheme for the construction of an intact
antibody model. (a) A model with a 4-4-8 hinge arrange-
ment. (b) The position of the center of the symmetrical axis
of the ellipsoid is represented as the Cartesian coordinates
(xc,yc,zc) and two spherical-polar angles (u and u). The
value u is the angle subtended by the main particle axis and
the Z axis, and u is the angle subtended by the projection of
the main particle axis on the (X,Y) plane and the X axis.
Figure adapted from Lu et al. (39).
TABLE 4 Shape functions from the best-ﬁt models for the IgG3
and its hinge mutants (IgG3m15 and IgG3HM5) IgG4
and IgG4S331P
Best-ﬁt model (s) P G Dmax (A˚)
IgG3wt 1.40 2.70 196
IgG3m15 1.28 1.68 163
IgG3HM5 1.27 1.60 164
IgG4wt A 1.27 1.58 162
B 1.28 1.65 162
IgG4S331P A 1.28 1.66 160
B 1.29 1.66 160
Note: Only one best-ﬁt model was found for IgG3wt, IgG3m15, and
IgG3HM5, two equivalent models (models A and B, see descriptions below)
were found for IgG4wt and IgG4S331P.
TABLE 5 Parameters of the best-ﬁt models for wild-type and


















Fc arm 90.0 0 88.2 — 80.2 196
Fab1 arm 111.9 243.6 8.7 79.5
Fab2 arm 99.4 326.8 3.8 84.4
(b) IgG3m15
Fc arm 90.0 0 19.8 — 108.0 163
Fab1 arm 64.0 17.9 3.9 23.7
Fab2 arm 69.0 254.2 3.2 23.0
(c) IgG3HM5
Fc arm 90.0 0 1.8 — 108.0 164
Fab1 arm 64.0 17.9 7.1 8.9
Fab2 arm 69.0 254.2 5.8 7.6
(d) Wild-type IgG4 model A with 2-2-2 hinge
Fc arm 90.0 0 9.0 — 122.4 162
Fab1 arm 65.6 176.3 3.72 12.72
Fab2 arm 57.4 4.6 4.85 13.85
(e) Wild-type IgG4 model B with 2-2-3 hinge
Fc arm 90.0 0 12.6 — 122.4 162
Fab1 arm 65.6 176.3 3.72 16.32
Fab2 arm 57.4 4.6 4.85 17.45
(f) IgG4S331P mutant model A
Fc arm 90.0 0 12.6 — 108.0 160
Fab1 arm 64.0 17.9 5.52 18.12
Fab2 arm 69.0 254.2 4.52 17.12
(g) IgG4S331P mutant model B
Fc arm 90.0 0 12.5 — 108.0 160
Fab1 arm 64.0 17.9 5.17 17.67
Fab2 arm 69.0 254.2 4.23 16.73
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Fig. 3 b shows the best-ﬁt model. It appears that in this
conformation the UH is not bent toward the Fc (suggested by
the acute u and positive values of projection on the Z axis in
Table 5(b)). Despite a truncated hinge, the two Fab arms of
the IgG3m15 seem to open up the molecule as demonstrated
by the unbent hinge and a wide Fab-Fab angle. Judging by
the projection on the Z axis, the hinge distances between the
two Fab domains relative to the Fc are similar (;23 A˚).
However, the two Fabs appear to distribute asymmetrically
along the long axis of the Fc (i.e., the Z axis), exposing one
side of the Fc ellipsoid proximal to the lower hinge region.
Bead modeling of IgG3HM5
The IgG3HM5 antibody is a hingeless antibody molecule.
Therefore, we ﬁrst tried to generate models without hinge
space. However, models without hinge beads construction
were unable to reproduce any of the experimental date (de-
tails not shown). This is consistent with our ﬁndings that the
solution characteristics (see Table 2) of IgG3HM5 appear to
resemble IgG4 rather than the compact hingeless antibody
Dob (11,21,54).
Bead modeling was then performed by constructing
models with a small but ﬁnite hinge or spacer-length be-
tween the domains by altering the number of beads in each
side chain (39). Three models (with 2-2-3, 3-3-3, and 4-4-0
hinge indices, respectively) were found that successfully
reproduced the experimental P- and G-values. Interestingly,
the model with a 4-4-0 hinge has a Dmax value that best
represents the experimental Dmax. The signiﬁcance of 4-4-0
is that, instead of a conventional Y-shape hinge region, this
model possesses a V-shape that modulates the orientations of
the two Fabs. Since IgG3HM5 is genetically constructed in a
way that no UH and MH are present, only the LH is retained
(see Table 1) (16,42); it is unlikely that there will be UH and
MH present in IgG3HM5, although they are present in IgG4.
We could postulate that the V-shape hinge region found in
the IgG3HM5 model is a feature of the LH in the molecule as
the LH is also believed to be ﬂexible (6). Another explana-
tion here is the V-shape hinge does not represent the actual
LH or the shape of the LH; instead, it is only an indicator of
the spatial separations between the three ellipsoids. Never-
theless, the V-shape hinge does appear to confer consider-
able degree of ﬂexibility within the IgG3HM5 molecule,
FIGURE 3 Best ﬁt models for wild-type and mutant
human IgG3s and IgG4s. In each case, the Fc domain (oblate
ellipsoid) is displayed at the bottom linked by a bent hinge to
the two Fab domains (prolate ellipsoids). The possible
regions of the C1q-binding motif in the CH2 region of Fc are
highlighted in white. (a) Model with a 6-6-24 hinge for wild-
type IgG3. (b) Model with a 2-2-5 hinge index for IgG3m15,
which has only 15 amino acids in the hinge region. (c)
Model for the hingeless mutant IgG3 HM5 with a 4-4-0
hinge. (d) Model with a 2-2-2 hinge index for wild-type
IgG4. (e) Model with a 3-3-3 hinge for the IgG4S331P
mutant.
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which could be an explanation for the high level of ring
dimers found in electron microscopy studies (32).
Details of this model are shown in Tables 4 and 5(c) and
Fig. 3 c: the two Fabs of IgG3HM5 have the same domain
orientations (thereby same Fab-Fab angle) as in IgG3m15.
However, IgG3HM5 has, as expected, a much limited hinge
length—only ;8 A˚ compared to ;24 A˚ for IgG3m15.
Bead modeling of wild-type IgG4
Of the 1600 candidate models, only two reproduced, within
experimental error, the experimental data in Table 2 for P, G,
and Dmax, which are described in Tables 4, 5(d), and 5(e):
these models are very similar to each other. The Fab arms in
one model (with a 2-2-2 hinge index, Fig. 3 d) and the other
model (with a 2-2-3 hinge index) adopts the same orientation
relative to the Fc. The difference in hinge length suggests
that when the domain dispositions are ﬁxed, the hinge length
could vary from ;13 A˚ to ;17 A˚, maintaining Dmax the
same. Thus, both models could be valid, and the degeneracy
in this case is simply an indication of some hinge ﬂexibility
in the wild-type IgG4.
Bead modeling of IgG4S331P
As with the case for wild-type IgG4, we found two equi-
valent and very similar models (i.e., same domain disposi-
tions) for the IgG4S331P mutant (with hinge length varying
from 17 A˚ to 18 A˚). Tables 4, 5(f), and 5(g) give the pa-
rameters and Fig. 3 e shows the model with a 3-3-3 hinge for
IgG4 S331P.
It is apparent that due to the single amino-acid substitution,
there is a signiﬁcant conformational change in IgG4S331P
(Fig. 3 e) compared with the wild-type IgG4 (see Fig. 3 d).
For both the mutant IgG4S331P and the wild-type IgG4, the
Fab arms stretch out and away from the Fc. However, it is
clear that one Fab arm in IgG4S331P rotates away from the
Fc and leads to an extreme asymmetrical conformation in
contrast to the conformation of IgG4, which shows itself as
highly symmetrical. The bead modeling also suggests that
the UH length and genetic hinge length of IgG4S331P is
slightly longer than the wild-type IgG4. The correlation
between the conformational changes with complement activ-
ation will be considered below.
Further validity check on the x-ray scattering data:
superimpositions of the distance distribution
function p(r)
The distance distribution function p(r) of a scattering particle
is directly related to the angular dependence of scattered
intensity that reﬂects the shape and mass distribution of the
molecule (57,59) and is used to calculate Dmax as considered
above. In the reﬁned crystallohydrodynamic approach (39),
we also proposed the inclusion of an ancillary procedure that
compares the full features of the experimental p(r) from
SAXS, with calculated p(r) from bead modeling using
SOLPRO (50,51,61). The experimental distance distribution
function from x-ray scattering can be normalized to unity to
superimpose with the distance distribution function from
modeling. Fig. 4 shows the superimposition of the experi-
mental p(r) with the modeled p(r) for each antibody using
SOLPRO.
The distance distribution function obtained from scatter-
ing represents a conformational average for a molecule with
some degree of ﬂexibility. By contrast, the SOLPRO calcu-
lation of p(r) is based on a static (ﬁlled) shell-bead model and
this simpliﬁed structure may explain why the computed
features in the p(r) distributions are blurred in the experi-
mental data, as demonstrated by Diaz and co-workers (61).
Polydispersity effects may also cause differences between the
experimental and calculated p(r) as well as the simpliﬁcations
we have made in representing the domains as (bead-shell)
ellipsoids. Agreement, however, between the experimental
and calculated values for the radius of gyration Rg and the
maximum dimension Dmax indicate that the ﬁlled shell-bead
models have captured the distribution of mass within the
antibody molecule correctly. There are some exaggerated
features (such as the bimodal peaks) in the computed p(r)
plots but this is simply due to the use of well-deﬁned shapes
(ellipsoids) for the individual domains in the geometrical
model (48).
The distance distribution function is a linear combination of
all the intraparticle scattering vectors in SAXS experiments.
The maxima M in a p(r) curve correspond to the most
frequently occurring interatomic distances within the struc-
ture (37). In all ﬁve antibodies investigated, the ﬁrst maxi-
mum M1 at 46–47 A˚ can be assigned to the most commonly
occurring distance in a single Fab or Fc fragment, which is
consistent with the average cross section (;45 A˚) found by
x-ray crystallography for the Fab and Fc (10). Peak M2,
between;76 and 83 A˚, describes the most common distance
within the whole antibody molecule. For the wild-type IgG3,
M1 is the distance in a Fab or Fc, M2 is assigned to the
distance between the two Fabs, and the third maximumM3 at
(129 6 1) A˚ is assigned to the greatest distance between the
Fab and Fc fragments that are held apart due to the existence
of the long hinge. This third maximum is not apparent in
either the IgG3 hinge mutants or the two IgG4 antibodies,
which indicates no distinguishable difference between the
Fab-Fab distance and the Fab-Fc distance—an observation
consistent with only a small (or no) hinge region within the
molecule.
DISCUSSION
Activation of complement through the classical pathway is
initiated by the interaction of the complement subcomponent
C1q and IgG molecules complexed to a membrane target
antigen. The C1q binding motif of mouse IgG2b seems to
involve Glu318, Lys320, and Lys322 in the CH2 region (62),
while human IgG1 and IgG3 appears to involve only
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Lys322, in addition to Asp270, Pro329, and Pro331 (63–65) (see
Fig. 5). Here a rationalization for the topography of this
complement-binding site on the Fc region is made and has
been highlighted in the models (see Fig. 3, a–e).
Wild-type IgG3 and its hinge mutants
For wild-type IgG3, the two Fabs are seen to bend toward
the Fc; however, they are positioned far away from the Fc
domain due to the existence of the long hinge (see Fig. 3 a).
Therefore, the complement-binding motif located in the Fc
region proximal to the lower hinge region is easy for C1q to
access and therefore it is not surprising that IgG3 is efﬁcient
in complement activation. The hinge region of IgG3wt has
also been visualized by electron microscopy as having a long
extension of 100–110 A˚ between the Fab and Fc regions
(31), slightly greater than 80–84 A˚ observed (under different
conditions) in this report. The mean Fab angle estimated by
FIGURE 4 Superimposition of the experimental (—) with the calculated p(r) plots (- - -) from bead modeling. (a) Wild-type IgG3; (b) IgG3m15; (c)
IgG3HM5; (d) wild-type IgG4; and (e) IgG4S331P. In panel a, SAXS peaksM1,M2, andM3 occur at;46 A˚, 83 A˚, and 129 A˚, respectively. The experimental
maximum dimension of ;195 A˚ is denoted as Dmax. In panels b–e, M1 occurs at ;46 A˚ and M2 at 76–80 A˚, respectively. For Dmax values, see Table 2.
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EM was 136, while our best-ﬁt model is more consistent
with a mean angle of 80, but again under different con-
ditions. Our present model of IgG3wt structure deviates
considerably from our ﬁrst crystallohydrodynamic approach
(33) and reﬂects the reﬁnement and the use of multiparam-
eters in our new strategy, resulting in a more accurate and
higher resolution of the IgG3wt model.
When focusing on the hinge mutants of IgG3, the en-
hanced complement-activation activity of IgG3m15 argue
against the view that the upper hinge length inﬂuences the
complement-activation activity (67). In fact, IgG3m15 forms
fewer ring dimers with an anti-idiotypic antibody than IgG3wt,
which indicates that IgG3m15 is less ﬂexible than IgG3wt
(32). Thus, enhanced complement activation of IgG3m15,
compared to IgG3wt, has previously been interpreted to be
due to C1q binding to the more rigid molecule. IgG3m15
may be more energetically favorable than binding to the
ﬂexible IgG3 molecule, as the loss of entropy on complex
formation is greater for a ﬂexible than for a rigid molecule
(15). This is consistent with our modeling of the domain
geometry, even at low resolution, that the solution confor-
mations of IgG3 wild-type and IgG3m15 are both favorable
for C1q binding, since IgG3m15 seems to expose the C1q
binding site (see Fig. 3 b) and have a sufﬁcient hinge space of
23 A˚ to allow C1q binding. It is also slightly asymmetric
along the Fc axis, similar to the IgG3wt. Extensive studies of
mutant chimeric human IgG3 have established that the
efﬁciency of C1 activation is not directly determined by the
length of the hinge region, but that at least one inter-heavy-
chain disulphide bridge is required (15,16,42,66).
Bead modeling of IgG3HM5 appears to establish that
there is no inter-heavy-chain disulphide bridge between the
two heavy chains, as shown by a V-shape hinge area in Fig.
3 c. The lack of an S-S link between the heavy chains
of IgG3HM5 (Fig. 1) is a structural consequence of hinge
deletion and has been conﬁrmed by SDS/PAGE analysis
(16). Since the spatial orientations for each domain in the
complement-inactive IgG3HM5 are the same as in the very
complement-active IgG3m15 (see Fig. 3 b), this suggests that,
if our hydrodynamic models are correct, the time-averaged
orientation of the Fab and Fc domains—although of
importance—is not the only controlling element in comple-
ment activation. Differences in the localization and position-
ing of the heavy-chain CH2 regions of IgG3HM5 compared
to IgG3m15 might be unfavorable for C1q binding, differ-
ences our low-resolution methodology cannot pick up. How-
ever, our modeling shows a small hinge space of 8 A˚, which
might be too small to facilitate C1q binding (Fig. 6).
Wild-type IgG4 and IgG4 S331P mutant
Using point mutants of chimeric antibodies, residue 331 has
been identiﬁed as a critical amino acid for determining the
isotypic differences in complement activation for human
IgG4 (18,19,43,67). It is here of interest to point out that
IgG4S331P mutant only activates complement at high anti-
gen concentration. Residue 331 is located in a peptide loop
between the last two b-strands of CH2 and is in close prox-
imity to the C1q-binding motif (19). Greenwood and col-
leagues (18) have postulated that the replacement of Pro
(which exists in IgG1 and IgG3) at position 331 with Ser)
may have a signiﬁcant effect on the tertiary structure of the
loop, such that elements of the IgG4 structure actively
prevent binding to an otherwise suitable site.
FIGURE 5 Crystal structure of a human Fc fragment taken from the Brook-
haven Protein Data Bank (accession code No. 1Fc1). Residues considered
most signiﬁcant for C1q binding are Lys322 (red), Pro329 (blue), and Pro331
(magenta).
FIGURE 6 Best-ﬁt models of IgG3m15 (dark shading) and IgG3HM5
(light shading) superimposed for comparison.
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In this study, bead modeling has shown that the replace-
ment of Ser to Pro at position 331 has dramatically altered
the domain orientations within the IgG4 molecule. As shown
in Fig. 3 e, the two Fabs in IgG4S331P adopt a much more
asymmetrical conformation when compared to the symmet-
rical wild-type IgG4 (see Fig. 3 d). This represents a sig-
niﬁcant reﬁnement of our previously published attempt on
human IgG4 (33) where, on the basis of sedimentation coef-
ﬁcient alone and its corresponding P-value (1.236 0.02), we
could only conclude on an open conformation (as opposed to
compact with the Fab arms folded down toward the Fc). Most
importantly, as with IgG3m15, one Fab arm in IgG4S331P
stretches away from the Fc, thereby leaving the C1q binding
site accessible. In the wild-type IgG4 molecule, however,
docking of complement C1q is obstructed by the two Fab
arms, which distribute symmetrically along the long axis of
the Fc ellipsoid.
It is our view that domain orientation (or dispositions)
seems to modulate the complement-activation ability for a
given antibody molecule. Antibodies that adopt conforma-
tions allowing docking of complement C1q are favorable for
complement activation, as demonstrated by IgG3m15 and
IgG4S331P. However, the inability of IgG3HM5 to induce
complement activation suggests that maintenance of at least
one inter-H-chain disulphide bond linking heavy chains at
the N-terminus of the lower hinge is a prior requirement for
complement activation. This may throw some light on the
role of the hinge region in controlling unrestricted ﬂexibility,
which would compromise the expression of biological effec-
tor function (15). Finally, our models all appear asymmet-
rical, with the exception of the wild-type IgG4. The limited
amount of crystal structures available for the intact anti-
bodies (24–27) are also asymmetrical. It would appear our
low-resolution solution models are at least consistent with
this theme. It is here relevant to mention that human IgG
seems to expose only one C1q binding site, perhaps as a
consequence of asymmetry (68).
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